Seaside Therapeutics
Cambridge
About Seaside Therapeutics
Seaside Therapeutics was founded to translate promising research discoveries into effective treatments for patients with autism, fragile X syndrome and other disorders of brain development. Our vision is to successfully develop breakthrough medications that will meaningfully improve the lives of individuals with these disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.0M
- Last round: Series Unknown (Sep 2009)
- Website: seasidetherapeutics.com
- Phone: +1 617-374-9009
Industries & Categories
Biotechnology, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/seaside-therapeutics-2452731 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.